Hester Biosciences has informed about submission of a transcript of Earnings Conference Call held by the Management of the Company with investors on 29 January 2019 at 2.00 pm to discuss the Unaudited Standalone Financial Results for the quarter and nine months ended on 31 December 2018.
The above information is a part of company’s filings submitted to BSE.